DEFINITIVE CONTRACT
Active75F40126C00104
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$10M
obligated · signed 2 months ago
FIRM FIXED PRICE AWARD LITIGATION SUPPORT SERVICES FREEDOM OF INFORMATION ACT (FOIA) COR: PAMELA WHETSTONE PAMELA.WHETSTONE@FDA.HHS.GOV CS: KIMBERLY W DAVIS KIMBERLY.DAVIS@FDA.HHS.GOV
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
AKIMA SECURE TECHNOLOGIES, LLC
Contract 75F40126C00104
UEI
CNR1C5KGVRC1
Parent Company
AKIMA SECURE TECHNOLOGIES, LLC
Capabilities & Certifications
Headquarters Location
Congressional District: 11
Current Obligation
$9,999,448
Base + Exercised Options
$9,999,448
Total Ceiling Value
$9,999,448
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES
PSC
SUPPORT- PROFESSIONAL: POLICY REVIEW/DEVELOPMENT
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.